Literature DB >> 16899466

Role of protein kinase C-mediated protein phosphorylation in mitochondrial translocation of mouse CYP1A1, which contains a non-canonical targeting signal.

Venkata Ramesh Dasari1, Hindupur K Anandatheerthavarada, Marie-Anne Robin, Ettickan Boopathi, Gopa Biswas, Ji-Kang Fang, Daniel W Nebert, Narayan G Avadhani.   

Abstract

A large number of mitochondrial proteins lack canonical mitochondrial-targeting signals. The bimodal transport of cytochromes P450 (CYPs) to endoplasmic reticulum and mitochondria (MT), reported previously by us, likely represents one mode of non-canonical protein targeting to MT. Herein, we have studied the mechanism of mouse MT-CYP1A1 targeting to gain insight into the regulatory features and evolutionary conservation of bimodal targeting mechanism. Mouse MT-CYP1A1 consists of two NH2-terminal-truncated molecular species, +91A1 and +331A1. Mutations Pro-2 --> Leu and Tyr-5 --> Leu, which increase the signal recognition particle (SRP) binding, diminished MT targeting of the protein in intact cells. By contrast, mutations Leu-7 --> Asn and Leu-17 --> Asn, which decreased SRP-binding affinity, enhanced MT targeting, thus suggesting that SRP binding is an important regulatory step that modulates bimodal targeting. Protein kinase C (PKC)-mediated phosphorylation of nascent chains at Thr-35 vastly decreased affinity for SRP binding suggesting an important regulatory step. In support of these results, COS cell transfection experiments show that phosphomimetic mutation Thr-35 --> Asp or induced cellular PKC caused increased CYP1A1 targeting to MT and correspondingly lower levels to the endoplasmic reticulum. Results suggest evolutionary conservation of chimeric signals and bimodal targeting of CYP1A1 in different species. The mouse MT-CYP1A1 is an extrinsic membrane protein, which exhibited high FDX1 plus FDXR-mediated N-demethylation of a number of tricyclic antidepressants, pain killers, anti-psychotics, and narcotics that are poor substrates for microsomal CYP1A1.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16899466     DOI: 10.1074/jbc.M510725200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

1.  Human liver mitochondrial cytochrome P450 2D6--individual variations and implications in drug metabolism.

Authors:  Michelle Cook Sangar; Hindupur K Anandatheerthavarada; Weigang Tang; Subbuswamy K Prabu; Martha V Martin; Miroslav Dostalek; F Peter Guengerich; Narayan G Avadhani
Journal:  FEBS J       Date:  2009-05-11       Impact factor: 5.542

Review 2.  Bimodal targeting of microsomal cytochrome P450s to mitochondria: implications in drug metabolism and toxicity.

Authors:  Michelle C Sangar; Seema Bansal; Narayan G Avadhani
Journal:  Expert Opin Drug Metab Toxicol       Date:  2010-10       Impact factor: 4.481

Review 3.  Cardiac mitochondrial matrix and respiratory complex protein phosphorylation.

Authors:  Raul Covian; Robert S Balaban
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-08-10       Impact factor: 4.733

4.  Mitochondria-targeted cytochrome P450 2E1 induces oxidative damage and augments alcohol-mediated oxidative stress.

Authors:  Seema Bansal; Chuan-Peng Liu; Naresh B V Sepuri; Hindupur K Anandatheerthavarada; Venkatesh Selvaraj; Jan Hoek; Ginger L Milne; F Peter Guengerich; Narayan G Avadhani
Journal:  J Biol Chem       Date:  2010-06-07       Impact factor: 5.157

5.  Gene structure and comparative and phylogenetic analyses of Catla catla CYP1A full-length cDNA and its responsiveness to benzo(a)pyrene and copper sulphate at early developmental stages.

Authors:  Kavita Kumari; Gireesh-Babu Pathakota; Shivendra Kumar; Gopal Krishna
Journal:  Fish Physiol Biochem       Date:  2017-08-19       Impact factor: 2.794

Review 6.  Bimodal targeting of cytochrome P450s to endoplasmic reticulum and mitochondria: the concept of chimeric signals.

Authors:  Narayan G Avadhani; Michelle C Sangar; Seema Bansal; Prachi Bajpai
Journal:  FEBS J       Date:  2011-10-24       Impact factor: 5.542

7.  Bimodal protein targeting through activation of cryptic mitochondrial targeting signals by an inducible cytosolic endoprotease.

Authors:  Ettickan Boopathi; Satish Srinivasan; Ji-Kang Fang; Narayan G Avadhani
Journal:  Mol Cell       Date:  2008-10-10       Impact factor: 17.970

8.  Mitochondrial P450-dependent arachidonic acid metabolism by TCDD-induced hepatic CYP1A5; conversion of EETs to DHETs by mitochondrial soluble epoxide hydrolase.

Authors:  Erin M Labitzke; Silvia Diani-Moore; Arleen B Rifkind
Journal:  Arch Biochem Biophys       Date:  2007-08-25       Impact factor: 4.013

9.  Knock-in mouse lines expressing either mitochondrial or microsomal CYP1A1: differing responses to dietary benzo[a]pyrene as proof of principle.

Authors:  Hongbin Dong; Timothy P Dalton; Marian L Miller; Ying Chen; Shigeyuki Uno; Zhanquan Shi; Howard G Shertzer; Seema Bansal; Narayan G Avadhani; Daniel W Nebert
Journal:  Mol Pharmacol       Date:  2008-12-01       Impact factor: 4.436

10.  Human cytochrome P450 2E1 mutations that alter mitochondrial targeting efficiency and susceptibility to ethanol-induced toxicity in cellular models.

Authors:  Seema Bansal; Hindupur K Anandatheerthavarada; Govindaswamy K Prabu; Ginger L Milne; Martha V Martin; F Peter Guengerich; Narayan G Avadhani
Journal:  J Biol Chem       Date:  2013-03-07       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.